Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation

bleeding disorders

Haemophilia Foundation Australia: Animals Can Have Bleeding Disorders Too!
Oct 6, 2025, 08:10 | Insight
Haemophilia Foundation Australia: Animals Can Have Bleeding Disorders Too!
Haemophilia Foundation Australia, shared a post on LinkedIn: "DidYouKnow – Animals can have bleeding disorders too!…
New Insights On Pre-Existing AAV5 Abs in Haemophilia B Gene Therapy
Oct 6, 2025, 03:48 | Science
New Insights On Pre-Existing AAV5 Abs in Haemophilia B Gene Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''Exited to share…
Emmanuel J Favaloro and Leonardo Pasalic's Commentary On Acquired von Willebrand Syndrome in Children
Oct 6, 2025, 03:40 | Science
Emmanuel J Favaloro and Leonardo Pasalic's Commentary On Acquired von Willebrand Syndrome in Children
Emmanuel J Favaloro, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared on LinkedIn:…
Gianluigi Pasta On Cutting-Edge Cartilage Engineering for Bleeding Disorders Community at EHC 2025
Oct 6, 2025, 03:20 | Insight
Gianluigi Pasta On Cutting-Edge Cartilage Engineering for Bleeding Disorders Community at EHC 2025
The European Haemophilia Consortium (EHC) shared on X: ''Advances in orthopaedics at EHC 2025! Gianluigi…
Nita Radhakrishnan and Colleagues on Tertiary Prophylaxis with Extended Half-life Factor in LMIC Settings
Oct 5, 2025, 12:43 | Science
Nita Radhakrishnan and Colleagues on Tertiary Prophylaxis with Extended Half-life Factor in LMIC Settings
Nita Radhakrishnan, Additional Professor and HOD, Department of Pediatric Hematology-Oncology, shared on X: ''Tertiary prophylaxis…
Miguel Crato: I Feel I Must Always Be Strong, But That Wears Me Down
Oct 5, 2025, 12:29 | Voices
Miguel Crato: I Feel I Must Always Be Strong, But That Wears Me Down
The European Haemophilia Consortium (EHC) shared on X: '''I feel I must always be strong,…
Nathan Connell: A Groundbreaking Study Has Just Been Published in Blood, From Vincent Muczynski and Colleagues
Oct 5, 2025, 08:11 | Science
Nathan Connell: A Groundbreaking Study Has Just Been Published in Blood, From Vincent Muczynski and Colleagues
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:…
Rucha Patil: I Had An Opportunity to Deliver a Lecture on A Topic Close to My Heart at EHA 2025
Oct 5, 2025, 07:56 | Insight
Rucha Patil: I Had An Opportunity to Deliver a Lecture on A Topic Close to My Heart at EHA 2025
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared…
Gaetan Duport about HTA and Reimbursement Models in Treatments for Bleeding Disorders
Oct 4, 2025, 10:26 | Insight
Gaetan Duport about HTA and Reimbursement Models in Treatments for Bleeding Disorders
The European Haemophilia Consortium (EHC) shared on X: ''Gaetan Duport about HTA and reimbursement models…
Read Jamie Madrigal, Dougald Monroe, Suzanne Sindi and Karin Leiderman's Latest Analysis on Emicizumab
Oct 4, 2025, 10:23 | Science
Read Jamie Madrigal, Dougald Monroe, Suzanne Sindi and Karin Leiderman's Latest Analysis on Emicizumab
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn: ''Mathematical analysis of emicizumab: affinity-driven complex…
Maria Elisa Mancuso: A Real Pleasure to Participate in The Policy Roundtable on Future of Haemophilia Care in Egypt
Oct 3, 2025, 14:41 | Voices
Maria Elisa Mancuso: A Real Pleasure to Participate in The Policy Roundtable on Future of Haemophilia Care in Egypt
Maria Elisa Mancuso, Senior Hematology Consultant at Humanitas Research Hospital, shared on LinkedIn: ''It has…
Quentin Van Thillo Shares His Latest Article on VWD: Grateful to Have Worked with Cedric Hermans 
Oct 3, 2025, 14:00 | Science
Quentin Van Thillo Shares His Latest Article on VWD: Grateful to Have Worked with Cedric Hermans 
Quentin Van Thillo, Haematologist at UZ Leuven, shared on LinkedIn: ''Our latest article on the…
Christian Pfrepper and Team's Letter on Emicizumab Plasma Concentration Measurment in EDTA plasma
Oct 3, 2025, 12:40 | Science
Christian Pfrepper and Team's Letter on Emicizumab Plasma Concentration Measurment in EDTA plasma
RPTH Journal shared on LinkedIn: ''It's mail day here at RPTH Journal Check out this…
No Extra Bleeding, Significant VTE Reduction․ Apixaban in Pediatric Obesity
Oct 2, 2025, 16:25 | Science
No Extra Bleeding, Significant VTE Reduction․ Apixaban in Pediatric Obesity
Blood Journals Portfolio shared a post on X: “Apixaban prophylaxis resulted in statistically significant reduction in…
Keith Gomez: Is Genetic Testing for Heritable Thrombocytopenia Coming of Age?
Oct 2, 2025, 14:09 | Science
Keith Gomez: Is Genetic Testing for Heritable Thrombocytopenia Coming of Age?
RPTH Journal shared on LinkedIn: ''Check out this commentary by Keith Gomez about genetic testing…
WFH Global Forum․ Exploring the Next Frontier in Bleeding Disorder Treatment
Oct 2, 2025, 07:46 | Organizations
WFH Global Forum․ Exploring the Next Frontier in Bleeding Disorder Treatment
World Federation of Hemophilia (WFH) shared on X: "Join Mike Makris and leading experts at…
Join the ISTH–EHA Webinar on Oct 29
Oct 2, 2025, 07:44 | Science
Join the ISTH–EHA Webinar on Oct 29
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared a…
Hemophilia Care is Entering a New Era
Oct 2, 2025, 07:37 | Organizations
Hemophilia Care is Entering a New Era
Hemophilia Federation (India) shared a post on LinkedIn: ”Hemophilia care is entering a new era!…
Persistent Mild Leukocytosis in Obesity․ Benign or Warning Sign?
Oct 2, 2025, 07:29 | Science
Persistent Mild Leukocytosis in Obesity․ Benign or Warning Sign?
William Aird, Professor of Medicine at Harvard Medical School, posted on X. ” Obesity can…
Caterina Casari - Prizes for Innovators 2025 Winner!
Oct 2, 2025, 04:59 | Innovation
Caterina Casari - Prizes for Innovators 2025 Winner!
Caterina Casari, Researcher (CRCN) at Inserm, reposted from Soufiane Carcaillet on LinkedIn: ''Today, I had…
2025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
Oct 2, 2025, 04:57 | Innovation
2025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
Romain Vidal, Deputy Director of Innovation, Research, and Higher Education in Île-de-France Region, shared on…
World Thrombosis Day 2025․ 8 Ways to Take Control and Save Lives
Oct 1, 2025, 16:35 | Voices
World Thrombosis Day 2025․ 8 Ways to Take Control and Save Lives
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared a…
Roberta Gualtierotti: We are excited to share GAJA! Towards More Accessible, Patient-Empowering Care in Hemophilia
Oct 1, 2025, 02:00 | Science
Roberta Gualtierotti: We are excited to share GAJA! Towards More Accessible, Patient-Empowering Care in Hemophilia
Roberta Gualtierotti, Associate Professor of Internal Medicine at University of Milan, shared on LinkedIn: ''Timely…
Davide Capodanno: Left Atrial Appendage Occlusion - the CLOSURE-AF Trial
Sep 30, 2025, 15:56 | Innovation
Davide Capodanno: Left Atrial Appendage Occlusion - the CLOSURE-AF Trial
Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, posted on X:…
JAK2V617F Screening in VTE․ New Evidence
Sep 30, 2025, 15:38 | Science
JAK2V617F Screening in VTE․ New Evidence
Mostafa Faisal Mohammed Saleh, Associate Professor of Clinical Hematology and HSCT at Assiut University, shared…
Wolfgang Miesbach: Jan Astermark at the BIC 2025 Presented Potentially the First Oral FVIII Mimetic Treatment for Hemophilia A
Sep 30, 2025, 11:43 | Insight
Wolfgang Miesbach: Jan Astermark at the BIC 2025 Presented Potentially the First Oral FVIII Mimetic Treatment for Hemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on Linkedin: ''For decades, oral…
Michael Makris: NovoNordisk Has Applied to the FDA for Approval of Mim8
Sep 29, 2025, 21:11 | Drugs
Michael Makris: NovoNordisk Has Applied to the FDA for Approval of Mim8
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, UK. Editor-in-Chief…
Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
Sep 29, 2025, 04:51 | Voices
Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
Vasculearn Network shared on LinkedIn: ''A major step forward for people living with hemophilia, and…
Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
Sep 29, 2025, 04:42 | Science
Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''The Bi8 Study…
ISCHEMIA Trial Update. Angina Relief With PCI, CABG, or Meds?
Sep 28, 2025, 11:12 | Insight
ISCHEMIA Trial Update. Angina Relief With PCI, CABG, or Meds?
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared…
UK ITP Treatment Update: Quentin Hill on Generic Eltrombopag Access and Guidance
Sep 27, 2025, 13:06 | Drugs
UK ITP Treatment Update: Quentin Hill on Generic Eltrombopag Access and Guidance
Quentin Hill, Consultant Haematologist at Leeds Teaching Hospitals NHS Trust, has shared a post on…
Brian O Mahony at HABIT Summit 2025 Showcases Hemophilia Community Across Latin America
Sep 27, 2025, 12:43 | Insight
Brian O Mahony at HABIT Summit 2025 Showcases Hemophilia Community Across Latin America
Brian O Mahony, CEO of Irish Haemophilia Society, Former President of WFH and EHC, shared…
Rameen Masood: How Should Abnormal Uterine Bleeding be Managed in People With Bleeding Disorders
Sep 27, 2025, 11:22 | Insight
Rameen Masood: How Should Abnormal Uterine Bleeding be Managed in People With Bleeding Disorders
RPTH journal shared a post on LinkedIn: "Rameen Masood and team formed a systematic review and…
Leonard Valentino on Hemophilia Care: Dr Keith Hoots Reflects on the History of HIV and AIDS
Sep 27, 2025, 11:09 | Voices
Leonard Valentino on Hemophilia Care: Dr Keith Hoots Reflects on the History of HIV and AIDS
Leonard Valentino, Former President and CEO of NBDF, President of WFH USA, shared on LinkedIn:…
Decoding FVIII Variants for Better Clinical Insights
Sep 26, 2025, 14:22 | Science
Decoding FVIII Variants for Better Clinical Insights
Blood Journals Portfolio shared a post on X: “The FVIII upgrade explains the effects of…
Uncovering the Thrombus Niche․ What We’ve Learned and What’s Next
Sep 26, 2025, 09:19 | Insight
Uncovering the Thrombus Niche․ What We’ve Learned and What’s Next
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of…
César Garrido Opened WFH Global Summit Sharing His Family's Experience With Hemophilia
Sep 25, 2025, 22:16 | Organizations
César Garrido Opened WFH Global Summit Sharing His Family's Experience With Hemophilia
World Federation of Hemophilia (WFH) shared on LinkedIn: ''Day 1 of the WFH Global Summit…
Discover Vienna on Foot: EHC 2025 Guided Evening Tour
Sep 24, 2025, 20:17 | Organizations
Discover Vienna on Foot: EHC 2025 Guided Evening Tour
The European Haemophilia Consortium (EHC) has recently shared a post on X: ” Join the…
Grifols Supports International ITP Awareness Week: Understanding Immune Thrombocytopenia
Sep 24, 2025, 12:32 | Insight
Grifols Supports International ITP Awareness Week: Understanding Immune Thrombocytopenia
Grifols has shared a post on LinkedIn: “Immune thrombocytopenia (ITP) is a rare autoimmune disorder…
Only One Month to ECTH 2025 – Secure Your Spot at Europe’s Premier Hemostasis Event
Sep 24, 2025, 11:20 | Organizations
Only One Month to ECTH 2025 – Secure Your Spot at Europe’s Premier Hemostasis Event
European Congress on Thrombosis and Haemostasis shared a post on LinkedIn: “Only one month to…
Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
Sep 24, 2025, 11:06 | Innovation
Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn: “Promising…
John Fanikos Praises Nathan Connell’s Efforts on Hemophilia Gene Therapy in Boston
Sep 24, 2025, 11:05 | Insight
John Fanikos Praises Nathan Connell’s Efforts on Hemophilia Gene Therapy in Boston
John Fanikos, Director of Strategic Initiatives at North American Thrombosis Forum, shared a post on…
Marilena Vrana on IPAW 2025: Celebrating Plasma Donors and Saving Lives
Sep 23, 2025, 08:59 | Insight
Marilena Vrana on IPAW 2025: Celebrating Plasma Donors and Saving Lives
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on…
Global Anaemia Reduction․ Insights from The Lancet Haem Commission
Sep 23, 2025, 07:06 | Insight
Global Anaemia Reduction․ Insights from The Lancet Haem Commission
The Lancet Haematology shared a post on X: ”Coauthor Dr Zhenyu Yang, Chinese Center for…
Bleeding Disorders and Mental Health․ From Stigma to Support
Sep 23, 2025, 07:05 | Organizations
Bleeding Disorders and Mental Health․ From Stigma to Support
EHC Haemophilia (The European Haemophilia Consortium) has shared a post on X: ”Powerful conversations today…
Caterina Casari: Privilege to Be Invited to The First VWD Summit
Sep 22, 2025, 22:20 | Voices
Caterina Casari: Privilege to Be Invited to The First VWD Summit
Caterina Casari, Researcher (CRCN) at Inserm, reposted from EHC  on LinkedIn: ''It was a privilege…
14th WFH Global Forum: From Gene Therapy and AI to VWD
Sep 22, 2025, 20:08 | Organizations
14th WFH Global Forum: From Gene Therapy and AI to VWD
World Federation of Hemophilia (WFH) shared on LinkedIn: ''The full program for the 14th WFH…
Wolfgang Miesbach Honors Glenn Pierce for His Insights into Hemophilia Care at BIC 2025
Sep 22, 2025, 19:45 | Insight
Wolfgang Miesbach Honors Glenn Pierce for His Insights into Hemophilia Care at BIC 2025
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''The future isn't…
Nathan Connell: New Research on Heavy Menstrual Bleeding in Women With von Willebrand Disease
Sep 22, 2025, 12:46 | Science
Nathan Connell: New Research on Heavy Menstrual Bleeding in Women With von Willebrand Disease
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:…
Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
Sep 22, 2025, 07:10 | Innovation
Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal,…
WFH: Hemophilia Innovations from Factor Therapy to Gene Therapy
Sep 21, 2025, 07:47 | Organizations
WFH: Hemophilia Innovations from Factor Therapy to Gene Therapy
World Federation of Hemophilia (WFH) shared on X: ”Hemophilia has led rare disease innovation—from factor…
Age and D-Dimer․ A New Cutoff for an Old Problem?
Sep 20, 2025, 15:57 | Organizations
Age and D-Dimer․ A New Cutoff for an Old Problem?
Thrombosis Canada posted on X: ”D-dimer, more false positives with age. But does an age-adjusted…
Cardiovascular Risk and MASLD - Integrating Lipid Management with Novel Agents
Sep 20, 2025, 15:35 | Science
Cardiovascular Risk and MASLD - Integrating Lipid Management with Novel Agents
Pablo Corral, Past President of Argentine Lipid Society, has shared a post on X: “Understanding…
Novo Nordisk Haemophilia Foundation Partners Drive Global Progress in Low-Dose Prophylaxis and Carrier Awareness
Sep 20, 2025, 13:58 | Organizations
Novo Nordisk Haemophilia Foundation Partners Drive Global Progress in Low-Dose Prophylaxis and Carrier Awareness
Novo Nordisk Haemophilia Foundation has shared a post on LinkedIn: “NNHF Partners Highlight Meeting We…
Historic Milestone: Munira Borhany Opens Pakistan’s First Female Bleeding Disorders Ward in Karachi
Sep 20, 2025, 13:42 | Voices
Historic Milestone: Munira Borhany Opens Pakistan’s First Female Bleeding Disorders Ward in Karachi
  Munira Borhany, hematologist/hemato‐oncologist at Dr. Ziauddin Hospital and Midciti Hospital, posted on LinkedIn: ''At…
Life With FVII Deficiency. Christy Miller’s Journey
Sep 20, 2025, 00:33 | Voices
Life With FVII Deficiency. Christy Miller’s Journey
National Bleeding Disorders Foundation shared on X: ”Christy Miller, is an educator, advocate, and mom…
ISTH Webinar on September 30th - From Guidance to Practice in APS Laboratory Testing
Sep 19, 2025, 17:06 | Organizations
ISTH Webinar on September 30th - From Guidance to Practice in APS Laboratory Testing
The International Society on Thrombosis and Hemostasis (ISTH), recently shared a post on X: “Join…
Boosting Joint Health in Hemophilia. The Added Value of Myofascial Therapy
Sep 19, 2025, 17:01 | Insight
Boosting Joint Health in Hemophilia. The Added Value of Myofascial Therapy
World Federation of Hemophilia (WFH) shared a post on X: “Can hands on therapy boost…
Coagulation Profiles Help Define Four Distinct Sepsis Subgroups
Sep 19, 2025, 09:12 | Innovation
Coagulation Profiles Help Define Four Distinct Sepsis Subgroups
Thrombosis and Haemostasis Journal (TH Open) shared a post on X: “Can coagulation parameters be…
Barbara Adams Krolak Supports World Patient Safety Day, Advocates Safer Care for Children and Newborns
Sep 19, 2025, 07:15 | Voices
Barbara Adams Krolak Supports World Patient Safety Day, Advocates Safer Care for Children and Newborns
Barbara Adams Krolak, Marketing Manager at ISTH, has shared a post on LinkedIn: “I'm proud…
ISTH Releases Updated Resource on Thrombosis Care
Sep 19, 2025, 00:50 | Insight
ISTH Releases Updated Resource on Thrombosis Care
The International Society on Thrombosis and Hemostasis (ISTH), shared a post on X: “Did you…
Twinning Program Launched: Botswana and Pacific Northwest Unite for Bleeding Disorder Care
Sep 18, 2025, 10:49 | Organizations
Twinning Program Launched: Botswana and Pacific Northwest Unite for Bleeding Disorder Care
World Federation of Hemophilia shared a post on LinkedIn: "Earlier this month, the Botswana Inherited Bleeding…
Living with Glanzmann Thrombasthenia․ Eliza VanZweden’s Story of Resilience and Advocacy
Sep 17, 2025, 10:49 | Voices
Living with Glanzmann Thrombasthenia․ Eliza VanZweden’s Story of Resilience and Advocacy
National Bleeding Disorders Foundation shared on X: ” Diagnosed at birth with Glanzmann thrombasthenia, Eliza…
Erin VanDyke: NBCA Centers of Excellence Aim to Improve Blood Clot Care
Sep 17, 2025, 10:36 | Organizations
Erin VanDyke: NBCA Centers of Excellence Aim to Improve Blood Clot Care
Erin VanDyke, Vice President of National Blood Clot Alliance Centers of Excellence, shared a post…
M Joseph John: Joint Health in Hemophilic Arthropathy
Sep 17, 2025, 09:52 | Science
M Joseph John: Joint Health in Hemophilic Arthropathy
The World Federation of Hemophilia (WFH) shared on LinkedIn: ''Can hands-on therapy boost outcomes? A…
Maha Othman - ''BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!''
Sep 17, 2025, 07:00 | Insight
Maha Othman - ''BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!''
Maha Othman, Editor-in-Chief of Current Opinion in Hematology Journal, Research Co-Lead at CanVECTOR Research Network,…
A New Era in Antiplatelet Therapy for CABG?
Sep 16, 2025, 14:59 | Innovation
A New Era in Antiplatelet Therapy for CABG?
Mattia Galli, Associate Editor of the European Heart Journal, shared a proud post on X:…
Advance Bleeding Disorders Care: Submit Your Abstract for WFH 2026 by December 1
Sep 16, 2025, 08:36 | Organizations
Advance Bleeding Disorders Care: Submit Your Abstract for WFH 2026 by December 1
World Federation of Hemophilia (WFH) shared a post on LinkedIn: “Abstract submissions for both oral…
Wolfgang Miesbach Highlights First Inhibitor Case After Hemophilia A Gene Therapy (Giroctocogene Fitelparvovec)
Sep 16, 2025, 02:44 | Innovation
Wolfgang Miesbach Highlights First Inhibitor Case After Hemophilia A Gene Therapy (Giroctocogene Fitelparvovec)
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn: “First reported…
Ivan Peyron Encourages You to Support Resaerch Targeting Rare Coagulation Diseases and Platelet Pathologies
Sep 15, 2025, 17:40 | Voices
Ivan Peyron Encourages You to Support Resaerch Targeting Rare Coagulation Diseases and Platelet Pathologies
Ivan Peyron, Research Engineer at INSERM, shared on LinkedIn: Support research! Bleeding disorders and clotting…
Zita Gacser: ''EHC Think Tank'' Registries for Bleeding Disorders
Sep 15, 2025, 16:52 | Organizations
Zita Gacser: ''EHC Think Tank'' Registries for Bleeding Disorders
Zita Gacser, Community and Projects Lead at EHC - European Haemophilia Consortium, reposted from EHC…
BIC2025 Insights Shared by Brian O Mahony: Rethinking VWF Levels, Blood Group, and Bleeding Risk
Sep 15, 2025, 14:20 | Insight
BIC2025 Insights Shared by Brian O Mahony: Rethinking VWF Levels, Blood Group, and Bleeding Risk
Brian O Mahony, CEO of Irish Haemophilia Society, Former President of WFH and EHC, shared…
Subcutaneous Prophylaxis for Hemophilia (With or Without Inhibitors) – Novo Nordisk and HFA Webinar
Sep 15, 2025, 08:26 | Organizations
Subcutaneous Prophylaxis for Hemophilia (With or Without Inhibitors) – Novo Nordisk and HFA Webinar
Hemophilia Federation of America (HFA) has shared a post on LinkedIn: “Join Novo Nordisk and…
Flora Peyvandi Closed BIC 2025 Thanking Glenn Pierce and Brian O' Mahony for Reminding Us of Our Impact on Patients
Sep 14, 2025, 18:21 | Insight
Flora Peyvandi Closed BIC 2025 Thanking Glenn Pierce and Brian O' Mahony for Reminding Us of Our Impact on Patients
Roberta Palla, post doctoral research fellow at the University of Milan, shared on X: ''Flora…
Thomas Kazmirchuk on AI-Generated Peptide Targeting Platelet-type von Willebrand Disease
Sep 14, 2025, 12:14 | Science
Thomas Kazmirchuk on AI-Generated Peptide Targeting Platelet-type von Willebrand Disease
Thomas Kazmirchuk, Associate Research Fellow at Queen's University, shared on LinkedIn: ''I am absolutely thrilled…
F8 Gene Variants Affect Desmopressin Response in Female Hemophilia A Carriers
Sep 14, 2025, 04:16 | Science
F8 Gene Variants Affect Desmopressin Response in Female Hemophilia A Carriers
Rare Disease Advisor has shared a post on LinkedIn: “The pharmacokinetic response of factor VIII…
Early Diagnosis and Care: Giving Children with Haemophilia the Chance to Thrive
Sep 13, 2025, 13:44 | Organizations
Early Diagnosis and Care: Giving Children with Haemophilia the Chance to Thrive
Kenya Haemophilia Association shared a post on LinkedIn. "Children with haemophilia can live healthy, happy, and…
Brian O Mahony on 5-Year Roctavian Gene Therapy Data from BIC2025
Sep 13, 2025, 13:34 | Voices
Brian O Mahony on 5-Year Roctavian Gene Therapy Data from BIC2025
Brian O Mahony, CEO of Irish Haemophilia Society, Former President of WFH and EHC, shared…
Ranjeet Ajmani Invites You To Join The AABB-AATM Joint Webinar on Plasma Fractionation
Sep 13, 2025, 10:49 | Insight
Ranjeet Ajmani Invites You To Join The AABB-AATM Joint Webinar on Plasma Fractionation
Ranjeet Ajmani, Chief Executive Officer- Asia at Aegros, shared on LinkedIn: ''Plasma-Derived Medicinal Products (PDMPs)…
Peter Lenting at BIC 2025: Fantastic Lecture on FVIII Mimetics
Sep 13, 2025, 10:23 | Insight
Peter Lenting at BIC 2025: Fantastic Lecture on FVIII Mimetics
HITh lab Inserm shared on LinkedIn: ''The HITh lab Inserm is at BIC 2025 in…
Emna Gouider Belhadjali on the Role of NMOs in Advocating for Equitable Access to Diagnosis for WGBDs
Sep 13, 2025, 06:49 | Voices
Emna Gouider Belhadjali on the Role of NMOs in Advocating for Equitable Access to Diagnosis for WGBDs
World Federation of Hemophilia (WFH) shared on LinkedIn: '''Bleeding disorders are not male diseases.' WFH…
Flora Peyvandi on Iron Deficiency in Mild to Moderate Bleeding Disorders
Sep 13, 2025, 01:37 | Science
Flora Peyvandi on Iron Deficiency in Mild to Moderate Bleeding Disorders
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of…
Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
Sep 12, 2025, 03:38 | Science
Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, has shared a…
Marstacimab Shows 93% Reduction in Treated Bleeds in its Phase 3 Trial
Sep 11, 2025, 13:37 | Drugs
Marstacimab Shows 93% Reduction in Treated Bleeds in its Phase 3 Trial
National Bleeding Disorders Foundation shared on LinkedIn: ''Promising news for the hemophilia community! Pfizer’s HYMPAVZI™…
Rivaroxaban vs Apixaban in AFib and PAD - What the Data Say
Sep 11, 2025, 08:32 | Insight
Rivaroxaban vs Apixaban in AFib and PAD - What the Data Say
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal,…
WFH at BDC 2025․ Advancing Global Bleeding Disorder Care
Sep 11, 2025, 08:31 | Organizations
WFH at BDC 2025․ Advancing Global Bleeding Disorder Care
The World Federation of Hemophilia (WFH) shared on X: ”In August, the WFH attended BDC…
Fellowship Opportunity in Hemostasis and Thrombosis Research
Sep 11, 2025, 08:29 | Science
Fellowship Opportunity in Hemostasis and Thrombosis Research
Bryce A. Kerlin, MD, Researcher in Thrombosis, Kidney Disease & Hemostasis has shared a post…
Plasmin Activity and VTE Prevention․ Surprising Insights
Sep 11, 2025, 08:09 | Insight
Plasmin Activity and VTE Prevention․ Surprising Insights
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of…
Al-Ola A Abdallah on MGUS-Related Bleeding Disorders
Sep 11, 2025, 08:08 | Voices
Al-Ola A Abdallah on MGUS-Related Bleeding Disorders
Al-Ola A Abdallah, Associate Professor and Director of the Plasma Cell Disorder Program at the…
FDA Approves VONVENDI for Adults With All Types of von Willebrand Disease
Sep 10, 2025, 20:45 | Drugs
FDA Approves VONVENDI for Adults With All Types of von Willebrand Disease
National Bleeding Disorders Foundation (NBDF) shared on LinkedIn: ''Big news for the bleeding disorders community:…
WHO Updates Essential Medicines List for Hemophilia and VWD: Louise Bannon Applauds Global Hematology Community’s Achievement
Sep 10, 2025, 15:02 | Drugs
WHO Updates Essential Medicines List for Hemophilia and VWD: Louise Bannon Applauds Global Hematology Community’s Achievement
Louise Bannon, Director of Membership, Marketing and External Relations of ISTH, shared a post on…
Iron Deficiency in Mild to Moderate Bleeding Disorders․ Key Insights from Prof. Flora Peyvandi
Sep 10, 2025, 08:06 | Science
Iron Deficiency in Mild to Moderate Bleeding Disorders․ Key Insights from Prof. Flora Peyvandi
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of…
Hemophilia Federation of America Launches ‘Blood Brothers’ Podcast for Men With Bleeding Disorders
Sep 9, 2025, 08:07 | Voices
Hemophilia Federation of America Launches ‘Blood Brothers’ Podcast for Men With Bleeding Disorders
  Hemophilia Federation of America (HFA) posted on X: ''Calling all Blood Brothers Are you…
Von Willebrand Disease. 2021 Guideline Recommendations Remain Strong
Sep 9, 2025, 08:04 | Organizations
Von Willebrand Disease. 2021 Guideline Recommendations Remain Strong
National Bleeding Disorders Foundation shared on X: ”A recent review of the 2021 international clinical…
Mortality Risk in Thrombotic Thrombocytopenic Purpura․ Insights from Laboratory Biomarkers
Sep 9, 2025, 07:56 | Insight
Mortality Risk in Thrombotic Thrombocytopenic Purpura․ Insights from Laboratory Biomarkers
Mostafa Faisal, Associate professor of Adult Hematology and BMT shared a post on X: “Prognostic…
WFH Global Forum Returns to Montreal - Register Now!
Sep 9, 2025, 05:37 | Organizations
WFH Global Forum Returns to Montreal - Register Now!
The World Federation of Hemophilia (WFH) shared on LinkedIn: ''The WFH Global Forum returns to…
Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
Sep 8, 2025, 14:24 | Innovation
Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
Thrombosis & Haemostasis Journal (TH Open) shared a post on X. “Von Willebrand Factor as…
GLP-1 Receptor Agonists and Cardiovascular Benefits․ Role of Clinical Features
Sep 8, 2025, 14:22 | Science
GLP-1 Receptor Agonists and Cardiovascular Benefits․ Role of Clinical Features
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal,…
French Reference Center for Hemophilia Presented at The 22nd Turkish Hemophilia Congress
Sep 8, 2025, 07:00 | Voices
French Reference Center for Hemophilia Presented at The 22nd Turkish Hemophilia Congress
CRH French Reference Center for Hemophilia Lyon shared on LinkedIn: ''At the 22nd Turkish Hemophilia…
Noa Kabera Joins EAHAD as Project Coordinator to Advance Haemophilia and Allied Disorders Care
Sep 8, 2025, 06:22 | Insight
Noa Kabera Joins EAHAD as Project Coordinator to Advance Haemophilia and Allied Disorders Care
European Association for Haemophilia and Allied Disorders (EAHAD) has shared a post on LinkedIn: “We…
All: 1967 Posts: 1701 - 1800
NewsFeed